Routine human papillomavirus genotyping by DNA sequencing in community hospital laboratories

Infectious Agents and Cancer

Volumn 2, Issue 1, 2007, Pages

  Lee, Sin Hang ^a   Vigliotti, Veronica S ^a   Vigliotti, Jessica S ^a   Pappu, Suri ^a  

^a Milford Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34347260279     PISSN: None     EISSN: 17509378     Source Type: Journal    
DOI: 10.1186/1750-9378-2-11     Document Type: Article

References (56)

1. Kjaer SK, van den Brule AJ, Bock JE, Poll PA, Engholm G, Sherman ME, Walboomers JM, Meijer CJ: Human papillomavirus- the most significant risk determinant of cervical intraepithelial neoplasia. Int J Cancer 1996, 65:601-6.
2. HC2 HPV DNA Test-REF 5199-1220 Digene Corporation, Gaithersburg, MD 20878 USA. 2005.
3. Gogola J, Van Dinh T, Lucci JA 3, Smith E, Hannigan EV: Human papillomavirus testing for triage in a referral population. J Low Genit Tract Dis 2001, 5:29-32.
4. ACOG Practice Bulletin No 61: Human Papillomavirus. Obstet Gynecol 2005, 105:905-18.
5. Wu HH, Allen SL, Kirkpatrick JL, Elsheikh TM: Reflex high-risk human papilloma virus DNA test is useful in the triage of women with atypical squamous cells cannot exclude high-grade squamous intraepithelial lesion. Diagn Cytopathol 2006, 34:707-10.
6. Wallin KL, Wiklund F, Angstrom T, Bergman F, Stendahl U, Wadell G, Hallmans G, Dillner J: Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer. N Engl J Med 1999, 341:1633-8.
7. Kjaer SK, van den Brule AJ, Paull G, Svare EI, Sherman ME, Thomsen BL, Suntum M, Bock JE, Poll PA, Meijers CJ: Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up study. BMJ 2002, 325:572-6.
8. Cuschieri KS, Cubie HA, Whitley MW, Gilkison G, Arends MJ, Graham C, McGoogan E: Persistent high risk HPV infection associated with development of cervical neoplasia in a prospective population study. J Clin Pathol 2005, 58:946-50.
9. Brummer O, Hollwitz B, Bohmer G, Kuhnle H, Petry KU: Human papillomavirus-type persistence patterns predict the clinical outcome of cervical intraepithelial neoplasia. Gynecol Oncol 2006, 102:517-22.
10. Jacobs MV, Walboomers JM, Snijders PJ, Voorhorst FJ, Verheijen RH, Fransen-Daalmeijer N, Meijer CJ: Distribution of 37 mucosotropic HPV types in women with cytologically normal cervical smears: the age-related patterns for high-risk and low-risk types. Int J Cancer 2000, 87:221-7.
11. Herrero R, Hildesheim A, Bratti C, Sherman ME, Hutchinson M, Morales J, Balmaceda I, Greenberg MD, Alfaro M, Burk RD, Wacholder S, Plummer M, Schiffman M: Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica. J Natl Cancer Inst 2000, 92:464-74.
12. Molano M, Posso H, Weiderpass E, van den Brule AJ, Ronderos M, Franceschi S, Meijer CJ, Arslan A, Munoz N, HPV Study Group HPV Study: Prevalence and determinants of HPV infection among Colombian women with normal cytology. Br J Cancer 2002, 87:324-33.
13. Rousseau MC, Pereira JS, Prado JC, Villa LL, Rohan TE, Franco EL: Cervical coinfection with human papillomavirus (HPV) types as a predictor of acquisition and persistence of HPV infection. J Infect Dis 2001, 184:1508-17.
14. Hinchliffe SA, van Velzen D, Korporaal H, Kok PL, Boon ME: Transience of cervical HPV infection in sexually active, young women with normal cervicovaginal cytology. Br J Cancer 1995, 72:943-5.
15. Brown DR, Shew ML, Qadadri B, Neptune N, Vargas M, Tu W, Juliar BE, Breen TE, Fortenberry JD: A longitudinal study of genital human papillomavirus infection in a cohort of closely followed adolescent women, J Infect Dis 2005, 191:182-92.
16. Cuschieri KS, Cubie HA, Whitley MW, Seagar AL, Arends MJ, Moore C, Gilkisson G, McGoogan E: Multiple high risk HPV infections are common in cervical neoplasia and young women in a cervical screening population, J Clin Pathol 2004, 57:68-72.
17. Wensveen CW, Kagie MJ, Nagelkerke NJ, Veldhuizen RW, Trimbos JB: Can viral load, semi-quantitatively evaluated, of human papillomavirus predict cytological or histological outcome in women with atypical squamous or glandular cells of undetermined significance cytology? Eur J Gynaecol Oncol 2005, 26:393-7.
18. Sherman ME, Wang SS, Wheeler CM, Rich L, Gravitt PE, Tarone R, Schiffman M: Determinants of human papillomavirus load among women with histological cervical intraepithelial neoplasia 3 : dominant impact of surrounding low-grade lesions. Cancer Epidemiol Biomarkers Prev 2003, 12:1038-44.
19. Castle PE, Schiffman M, Burk RD, Wacholder S, Hildesheim A, Herrero R, Bratti MC, Sherman ME, Lorincz A: Restricted Cross-Reactivity of Hybrid Capture 2 with Nononcogenic Human Papillomavirus Types. Cancer Epidemiol Biomarkers & Prev 2002, 11:1394-9.
20. Vernon SD, Ungar ER, Williams D: Comparison of human papillomavirus detection and typing by cycle sequencing, line blotting, and hybrid capture. J Clin Microbiol 2000, 38:651-5.
21. Johnson T, Bryder K, Corbet S, Fomsgaard A: Routine genotyping of human papillomavirus samples in Denmark. APMIS 2003, 111:398-404.
22. Speich N, Schmitt C, Bollmann R, Bollmann M: Human papillomavirus (HPV) study of 2916 cytological samples by PCR and DNA sequencing : genotype spectrum of patients from the west German area, J Med Microbiol 2004, 53:125-8.
23. Kosel S, Burggraf S, Mommsen J, Engelhardt W, Olgemoller B: Type-specific detection of human papillomaviruses in a routine laboratory setting-improved sensitivity and specificity of PCR and sequence analysis compared to direct hybridisation. Clin Chem Lab Med 2003, 41:787-91.
24. Lonky NM, Felix JC, Naidu YM, Wolde-Tsadik G: Triage of atypical squamous cells of undetermined significance with hybrid capture II: colposcopy and histologic human papillomavirus correlation. Obstet Gynecol 2003, 101:481-9.
25. Stoler MH, Castle PE, Solomon D, Schiffman M: The Expanded Use of HPV Testing in Gynecologic Practice per ASCCP-Guided Management Requires the Use of Well-Validated Assays. Am J Clin Pathol 2007, 127:335-7.
26. VRBPAC Background Document: Gardasil™ HPV Quadrivalent Vaccine. VRBPAC Meeting [http://www.fda.gov/ohrms/dockets/ac/06/ briefing/2006-4222B3.pdf]. May 18, 2006
27. Asato T, Maehama T, Nagai Y, Kanazawa K, Uezato H, Kariya K: A large case-control study of cervical cancer risk associated with human papillomavirus infection in Japan, by nucleotide sequencing-based genotyping. J Infect Dis 2004, 189:1829-32.
28. [http://www.uri.edu/research/gsc/resources/cndna.html].
29. Protocols used at NCI & Related Information-Processing of Microdissected Tissue for Molecular Analysis [http://cgap-mf.nih.gov/ Protocols/Processing/DNA.html]
30. Ayatollahi M, Zakerinia M, Haghshenas M: Molecular analysis of Iranian families with sickle cell disease. J Trop Pediatr 2005, 51:136-40.
31. Gharizadeh B, Oggionni M, Zheng B, Akom E, Pourmand N, Ahmadian A, Wallin KL, Nyren P: Type-specific multiple sequencing primers: a novel strategy for reliable and rapid genotyping of human papillomaviruses by pyrosequencing technology. J Mol Diagn 2005, 7:198-205.
32. Feoli-Fonseca JC, Oligny LL, Filion M, Brochu P, Simard P, Russo PA, Yotov WV: A two-tier polymerase chain reaction direct sequencing method for detecting and typing human papillomaviruses in pathological specimens. Diagn Mol Pathol 1998, 7:317-23.
33. Ye S, Hong G: Heat-stable DNA polymerase I large fragment resolves hairpin structure in DNA sequencing. Scientia sinica (Series B) 1987, 30:503-6.
34. Earley JJ, Kuivaniemi H, Prockop DJ, Tromp G: Robotic automation of dideoxyribonucleotide sequencing reactions. Biotechniques 1994, 17:156-65.
35. Hong GF, Huang W: DNA polymerase having ability to reduce innate selective discrimination against fluorescent dyelabeled dideoxynucleotides. US Patent .#6,165,765
36. Andre P, Kim A, Khrapko K, Thilly WG: Fidelity and mutational spectrum of Pfu DNA polymerase on a human mitochondrial DNA sequence. Genome Res 1997, 7:843-52.
37. Lindahl T, Nyberg B: Rate of depurination of native deoxyribonucleicacid. Biochemistry 1972, 11:3610-8.
38. Lindahl T, Nyberg B: Heat-induced deamination of cytosine residues in deoxyribonucleic acid. Biochemistry 1974, 13:3405-10.
39. Evans MF, Adamson CS, Simmons-Arnold L, Cooper K: Touchdown General Primer (GP5+/GP6+) PCR and optimized sample DNA concentration support the sensitive detection of human papillomavirus. BMC Clin Pathol 2005. 5:10.
40. Schiffman M, Wheeler CM, Dasgupta A, Solomon D, Castle PE: The ALTS Group. A comparison of a prototype PCR assay and hybrid capture 2 for detection of carcinogenic human papillomavirus DNA in women with equivocal or mildly abnormal Papanicolaou smears. Am J Clin Pathol 2005, 124:722-32.
41. Tornesello ML, Duraturo ML, Salatiello I, Buonaguro L, Losito S, Botti G, Stellato G, Greggi S, Piccoli R, Pilotti S, Stefanon B, De Palo G, Franceschi S, Buonaguro FM: Analysis of human papillomavirus type-16 variants in Italian women with cervical intraepithelial neoplasia and cervical cancer. J Med Virol 2004, 74:117-26.
42. Feoli-Fonseca JC, Oligny LL, Brochu P, Simard P, Falconi S, Yotov VW: Human papillomavirus (HPV) study of 691 pathological specimens from Quebec by PCR-direct sequencing approach. J Med Virol 2001, 63:284-92.
43. Ortiz M, Torres M, Munoz L, Fernandez-Garcia E, Canals J, Cabornero AI, Aguilar E, Ballesteros J, Del Amo J, Garcia-Saiz A: Oncogenic human papillomavirus (HPV) type distribution and HPV type 16 E6 variants in two Spanish population groups with different levels of HPV infection risk. J Clin Microbiol 2006, 44:1428-34.
44. Anderson TP, Werno AM, Beynon KA, Murdoch DR: Failure To Genotype Herpes Simplex Virus by Real-Time PCR Assay and Melting Curve Analysis Due to Sequence Variation within Probe Binding Sites. J Clin Microbiol 2003, 41:2135-2137.
45. Goris J, Konstantinidis KT, Klappenbach JA, Coenye T, Vandamme P, Tiedje JM: DNA-DNA hybridization values and their relationship to whole-genome sequence similarities, Int J Syst Evol Microbiol 2007, 57:81-91.
46. Huang CC, Qiu JT, Kashima ML, Kurman RJ, Wu TC: Generation of type-specific probes for the detection of single-copy human papillomavirus by a novel in situ hybridization method. Mod Pathol 1998, 11:971-7.
47. Naef F, Lim DA, Patil N, Magnasco M: DNA hybridization to mismatched templates: a chip study. Phys Rev E Stat Nonlin Soft Matter Phys 2002, 65(4 Pt 1):040902.
48. Sorokin NV, Chechetkin VR, Livshits MA, Pan'kov SV, Donnikov MY, Gryadunov DA, Lapa SA, Zasedatelev AS: Discrimination between perfect and mismatched duplexes with oligonucleotide gel microchips: role of thermodynamic and kinetic effects during hybridization. J Biomol Struct Dyn 2005, 22:725-34.
49. Schmitt M, Bravo IG, Snijders PJ, Gissmann L, Pawlita M, Waterboer T: Bead-based multiplex genotyping of human papillomaviruses. J Clin Microbiol 2006, 44:504-12.
50. Tawheed AR, Beaudenon S, Favre M, Orth G: Characterization of human papillomavirus type 66 from an invasive carcinoma of the uterine cervix. J Clin Microbiol 1991, 29:2656-2660.
51. Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, Snijders PJ, Meijer CJ: International Agency for Research on Cancer Multicenter Cervical Cancer Study Group: Epidemiologie classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003, 348:518-27.
52. Prado JC, Calleja-Macias IE, Bernard HU, Kalantari M, Macay SA, Allan B, Williamson AL, Chung LP, Collins RJ, Zuna RE, Dunn ST, OrtizLopez R, Barrera-Saldana HA, Cubie HA, Cuschieri K, von Knebel-Doeberitz M, Sanchez GI, Bosch FX, Villa LL: Worldwide genomic diversity of the human papillomaviruses-53, 56, and 66, a group of high-risk HPVs unrelated to HPV-16 and HPV-18. Virology 2005, 340:95-104.
53. Favre M, Kremsdorf D, Jablonska S, Obalek S, Pehau-Arnaudet G, Croissant O, Orth G: Two new human papillomavirus types (HPV54 and 55) characterized from genital tumours illustrate the plurality of genital HPVs. Int J Cancer 1990, 45:40-6.
54. Schiff M, Becker TM, Masuk M, van Asselt-King L, Wheeler CM, Altobelli KK, North CQ, Nahmias AJ: Risk factors for cervical intraepithelial neoplasia in southwestern American Indian women. Am J Epidemiol 2000, 152:716-26.
55. Trimble CL, Piantadosi S, Gravitt P, Ronnett B, Pizer E, Elko A, Wilgus B, Yutzy W, Daniel R, Shah K, Peng S, Hung C, Roden R, Wu TC, Pardoll D: Spontaneous regression of high-grade cervical dysplasia: effects of human papillomavirus type and HLA phenotype. Clin Cancer Res 2005, 11:4717-23.
56. Zuna RE, Allen RA, Moore WE, Mattu R, Dunn ST: Comparison of human papillomavirus genotypes in high-grade squamous intraepithelial lesions and invasive cervical carcinoma : evidence for differences in biologic potential of precursor lesions. Modern Pathology 2004, 17:1314-22.